UK
-
UK insurer's 'defensive' investment status made it popular with investors -
The UK biotech company has chosen to list on its home market rather than go to the Nasdaq in New York, the traditional listing venue for companies in the industry
-
Private equity assets tempt investors in volatile markets
-
-
The French bank can’t afford to give up on to its UK equity capital markets business as it plots a path to a top three spot in European ECM over the next five years, writes David Rothnie
-
Oxford Nanopore has decided to list on its home exchange rather than the Nasdaq in New York
-
UK brokerage has decided to float again after a 21 year absence
-
Burnett had joined BNP Paribas in 2018 as part of a push into UK equity capital markets
-
International firms are flocking to the market despite allure of euros and dollars
-
His replacement at UK M&A regulator is UBS's Hart
-
Budget carrier catches out market with capital raising plan
-
Two semi-frequent issuers have kicked off what is set to be a busy week for sterling
